These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 8580059)

  • 21. Successful chemotherapy on a pregnant non-Hodgkin's lymphoma patient.
    Toki H; Okabe K; Kamei H; Shimokawa T; Hiura M; Kondo M; Hirota Y
    Acta Med Okayama; 1990 Dec; 44(6):321-3. PubMed ID: 2075830
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Constitutional translocation (8;13) in a patient with non-Hodgkin's lymphoma.
    Salles MT; Neyra O; Taja L; Cervantes G; Gagnière M; Cerrillo M; Mohar A; Osornio A; Reynoso E; Gorodezky G
    Cancer Genet Cytogenet; 1992 Mar; 59(1):80-3. PubMed ID: 1372839
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Defining the stages of aggressive non-Hodgkin's lymphoma--a work in progress.
    Armitage JO
    N Engl J Med; 2005 Mar; 352(12):1250-2. PubMed ID: 15788502
    [No Abstract]   [Full Text] [Related]  

  • 24. What is the treatment of choice for advanced-stage Hodgkin's lymphoma: ABVD, Stanford V, or BEACOPP?
    Hehn ST; Miller TP
    Curr Hematol Rep; 2004 Jan; 3(1):17-26. PubMed ID: 14695845
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Progression-free survival of early interim PET-positive patients with advanced stage Hodgkin's lymphoma treated with BEACOPP
    Borchmann P; Haverkamp H; Lohri A; Mey U; Kreissl S; Greil R; Markova J; Feuring-Buske M; Meissner J; Dührsen U; Ostermann H; Keller U; Maschmeyer G; Kuhnert G; Dietlein M; Kobe C; Eich H; Baues C; Stein H; Fuchs M; Diehl V; Engert A
    Lancet Oncol; 2017 Apr; 18(4):454-463. PubMed ID: 28236583
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Lactic acidosis in non-Hodgkin's lymphoma].
    Navigante AH; Chacón RD
    Medicina (B Aires); 1985; 45(6):667-9. PubMed ID: 2431249
    [No Abstract]   [Full Text] [Related]  

  • 27. T cell non-Hodgkin's lymphoma presenting in the first trimester of pregnancy.
    Lees CC; Tsirigotis M; Carr JV; Richards MA
    Postgrad Med J; 1994 May; 70(823):371-2. PubMed ID: 8016012
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Biweekly CHOP-E chemotherapy for aggressive non-Hodgkin's lymphoma].
    Hayashi T; Takahashi T; Mihara M; Shimizu H; Tsukuda H; Kobayashi T; Adachi M; Hinoda Y; Aoki S; Mori M; Tsujisaki M; Imai K
    Gan To Kagaku Ryoho; 1997 May; 24(7):889-91. PubMed ID: 9170532
    [No Abstract]   [Full Text] [Related]  

  • 29. Advanced diffuse non-Hodgkin's lymphoma. Analysis of prognostic factors by the international index and by lactic dehydrogenase in an intergroup study.
    Gordon LI; Andersen J; Colgan J; Glick J; Resnick GD; O'Connell M; Cassileth PA
    Cancer; 1995 Feb; 75(3):865-73. PubMed ID: 7530168
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Unfavorable histologies of non-Hodgkin's lymphoma treated with ProMACE-CytaBOM: a groupwide Southwest Oncology Group study.
    Miller TP; Dahlberg S; Weick JK; Files JC; Eyre HJ; Pendergrass KB; Fisher RI
    J Clin Oncol; 1990 Dec; 8(12):1951-8. PubMed ID: 1700079
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Successful treatment of primary gastric non-Hodgkin's lymphoma with chemotherapy and radiotherapy.
    Tsukada K; Arima K; Ohosone Y; Hanada T; Mita S; Harada K; Matsuoka Y; Irimajiti S; Fukuda J
    Intern Med; 1992 Mar; 31(3):368-72. PubMed ID: 1377061
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transplantation potential of peripheral whole blood primed by VACOP-B chemotherapy plus filgrastim (r-metHuG-CSF) in patients with aggressive non-Hodgkin's lumphoma.
    Corato A; Ambrosetti A; Rossi B; Vincenzi C; Lambiase A; Perona G; Pizzolo G; de Wynter E; Nadali G
    J Hematother Stem Cell Res; 2000 Oct; 9(5):673-82. PubMed ID: 11091491
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Update: NCCN non-Hodgkin's lymphoma clinical practice guidelines.
    Czuczman MS
    J Natl Compr Canc Netw; 2004 Sep; 2 Suppl 3():S-46-52. PubMed ID: 23570100
    [No Abstract]   [Full Text] [Related]  

  • 34. Southwest Oncology Group clinical trials for intermediate- and high-grade non-Hodgkin's lymphomas.
    Miller TP; Dana BW; Weick JK; Jones SE; Coltman CA; Dahlberg S; Fisher RI
    Semin Hematol; 1988 Apr; 25(2 Suppl 2):17-22. PubMed ID: 2456619
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cyclophosphamide, epirubicin, vincristine, prednisone, bleomycin, etoposide (CEOP-BE) therapy for intermediate- and high-grade non-Hodgkin's lymphomas.
    Mugitani A; Tatsumi Y; Tanaka K; Yasui Y; Inoue T
    Anticancer Res; 1999; 19(4C):3393-7. PubMed ID: 10629625
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Primary mediastinal large B-cell lymphoma (PMLBCL): long-term results from a retrospective multicentre Italian experience in 138 patients treated with CHOP or MACOP-B/VACOP-B.
    Todeschini G; Secchi S; Morra E; Vitolo U; Orlandi E; Pasini F; Gallo E; Ambrosetti A; Tecchio C; Tarella C; Gabbas A; Gallamini A; Gargantini L; Pizzuti M; Fioritoni G; Gottin L; Rossi G; Lazzarino M; Menestrina F; Paulli M; Palestro M; Cabras MG; Di Vito F; Pizzolo G
    Br J Cancer; 2004 Jan; 90(2):372-6. PubMed ID: 14735179
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of four different regimens in 64 mantle-cell lymphoma cases: clinicopathologic comparison with 498 other non-Hodgkin's lymphoma subtypes. European Organization for the Research and Treatment of Cancer Lymphoma Cooperative Group.
    Teodorovic I; Pittaluga S; Kluin-Nelemans JC; Meerwaldt JH; Hagenbeek A; van Glabbeke M; Somers R; Bijnens L; Noordijk EM; Peeters CD
    J Clin Oncol; 1995 Nov; 13(11):2819-26. PubMed ID: 7595744
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term follow-up of non-Hodgkin's lymphoma patients treated with ProMACE-CytaBOM: an effective regimen for the intermediate grade subtype.
    Marotta G; Bigazzi C; Bocchia M; Forconi F; Lauria F
    Haematologica; 1998 Sep; 83(9):853-4. PubMed ID: 9825583
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Results of treatment with high intensity, brief duration chemotherapy in poor prognosis non-Hodgkin's lymphoma.
    McMaster ML; Greer JP; Wolff SN; Johnson DH; Greco FA; Stein RS; Cousar JB; Flexner JM; Hainsworth JD
    Cancer; 1991 Jul; 68(2):233-41. PubMed ID: 1712662
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effective therapy for poor-prognosis non-Hodgkin's lymphoma with 8 weeks of high-dose-intensity combination chemotherapy.
    Waits TM; Greco FA; Greer JP; Johnson DH; Wolff SN; Stein RS; McMaster ML; Hainsworth JD
    J Clin Oncol; 1993 May; 11(5):943-9. PubMed ID: 7683712
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.